These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity. Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472 [TBL] [Abstract][Full Text] [Related]
4. [Angiotensin-converting enzyme and its physiological role]. Eliseeva IuE Vopr Med Khim; 2001; 47(1):43-54. PubMed ID: 11385998 [TBL] [Abstract][Full Text] [Related]
5. Development of domain-selective angiotensin I-converting enzyme inhibitors. Redelinghuys P; Nchinda AT; Sturrock ED Ann N Y Acad Sci; 2005 Nov; 1056():160-75. PubMed ID: 16387685 [TBL] [Abstract][Full Text] [Related]
6. Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzyme. Jullien ND; Cuniasse P; Georgiadis D; Yiotakis A; Dive V FEBS J; 2006 Apr; 273(8):1772-81. PubMed ID: 16623712 [TBL] [Abstract][Full Text] [Related]
7. Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain. Georgiadis D; Cuniasse P; Cotton J; Yiotakis A; Dive V Biochemistry; 2004 Jun; 43(25):8048-54. PubMed ID: 15209500 [TBL] [Abstract][Full Text] [Related]
8. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors. Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239 [TBL] [Abstract][Full Text] [Related]
9. Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway? Husain A; Li M; Graham RM Circ Res; 2003 Jul; 93(2):91-3. PubMed ID: 12881473 [No Abstract] [Full Text] [Related]
10. Homologous substitution of ACE C-domain regions with N-domain sequences: effect on processing, shedding, and catalytic properties. Woodman ZL; Schwager SL; Redelinghuys P; Chubb AJ; van der Merwe EL; Ehlers MR; Sturrock ED Biol Chem; 2006 Aug; 387(8):1043-51. PubMed ID: 16895474 [TBL] [Abstract][Full Text] [Related]
11. Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype. van Esch JH; van Gool JM; de Bruin RJ; Payne JR; Montgomery HE; Hectors M; Deinum J; Dive V; Jan Danser AH J Hypertens; 2008 Apr; 26(4):706-13. PubMed ID: 18327080 [TBL] [Abstract][Full Text] [Related]
12. Advances in Structural Biology of ACE and Development of Domain Selective ACE-inhibitors. Polakovičová M; Jampílek J Med Chem; 2019; 15(6):574-587. PubMed ID: 31084594 [TBL] [Abstract][Full Text] [Related]
13. Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme. Skirgello OE; Binevski PV; Pozdnev VF; Kost OA Biochem J; 2005 Nov; 391(Pt 3):641-7. PubMed ID: 16033330 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design. Corradi HR; Schwager SL; Nchinda AT; Sturrock ED; Acharya KR J Mol Biol; 2006 Mar; 357(3):964-74. PubMed ID: 16476442 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal Antibodies 1G12 and 6A12 to the N-domain of human angiotensin-converting enzyme: fine epitope mapping and antibody-based detection of ACE inhibitors in human blood. Balyasnikova IV; Skirgello OE; Binevski PV; Nesterovitch AB; Albrecht RF; Kost OA; Danilov SM J Proteome Res; 2007 Apr; 6(4):1580-94. PubMed ID: 17326675 [TBL] [Abstract][Full Text] [Related]
16. Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme. Binevski PV; Sizova EA; Pozdnev VF; Kost OA FEBS Lett; 2003 Aug; 550(1-3):84-8. PubMed ID: 12935891 [TBL] [Abstract][Full Text] [Related]
17. Structure-function discrimination of the N- and C- catalytic domains of human angiotensin-converting enzyme: implications for Cl- activation and peptide hydrolysis mechanisms. Tzakos AG; Galanis AS; Spyroulias GA; Cordopatis P; Manessi-Zoupa E; Gerothanassis IP Protein Eng; 2003 Dec; 16(12):993-1003. PubMed ID: 14983080 [TBL] [Abstract][Full Text] [Related]
19. The influence of angiotensin converting enzyme mutations on the kinetics and dynamics of N-domain selective inhibition. Lubbe L; Sewell BT; Sturrock ED FEBS J; 2016 Nov; 283(21):3941-3961. PubMed ID: 27636235 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the first non-insect invertebrate functional angiotensin-converting enzyme (ACE): leech TtACE resembles the N-domain of mammalian ACE. Rivière G; Michaud A; Deloffre L; Vandenbulcke F; Levoye A; Breton C; Corvol P; Salzet M; Vieau D Biochem J; 2004 Sep; 382(Pt 2):565-73. PubMed ID: 15175004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]